China Practice — Life Sciences

Our China practice lawyers have more than thirty years of pioneering experience assisting Chinese, Hong Kong and foreign parties with local and cross-border China-related legal matters. Our team's leading role in the earliest developments in business and law in China includes extensive experience advising life sciences companies on a wide range of China-related legal issues. Below is a representative selection of our China-related life sciences clients and matters: 

Ansell Limited                        

• Due Diligence Report for Ansell Limited regarding proposed acquisition of Wuhan Jissbon Sanitary Product Co., Ltd.
• Joint Investment and Marketing MOU between Ansell Healthcare and Humanwell High Technology Industry Co., Ltd.
• Establishment of Ansell’s Wholly Foreign-Owned Wholesale Enterprise in Shanghai and advice on operation of a branch company
• Advice on expatriate employment and performance share rights incentive plans 
• Advice on the buyout of a Beijing joint venture

Applied Biosystems Group

• Provided training on Foreign Corrupt Practices Act and other issues of corporate conduct
• Consultancy/Finder’s Agreement with respect to procuring purchasers for the products of Applied Biosystems
• Advice on establishing a company in the Waigaoqiao Free Trade Zone in China
• Creation of General Terms of Sale form to be applied in China

Aventis Behring

• Advice on licensing options regarding contracting a company in mainland China to manufacture Aventis Behring’s plasma products
• Advice regarding the registration of Aventis Behring’s trademarks
• Advice on selling pharmaceuticals and establishing a Representative Office in China

Calypte Biomedical Corporation

• Assistance with acquisition of a domestic pharmaceutical company and the restructuring of its China operations
• Assistance with corporate reorganization and business expansion plan
• Advice on industry-specific regulatory issues regarding drug manufacturing and pharmaceutical company operations

Dade Behring Holdings, Inc.

• Ongoing representation with respect to product registration and distribution of medical devices and pharmaceuticals
• Dispute settlement with various distributors
• Advice concerning Chinese regulatory compliance
• Advice with respect to new draft regulations on medical instruments in China
• Advice concerning Dade Behring’s ongoing legal issues related to their China activities
• Structuring and establishment of business entities in China

Polichem S.A.

• Assistance with the establishment of its Chinese operations
• Assistance with the registration of medical products in China

Pfizer Inc.

• Advised Pfizer Inc. in the sale of the China operations of Schick Division to Energizer Holdings for US$410 million
• Advised Pfizer Inc. on the sale of China operations of Adams Division to Cadbury Schweppes for US$50 million

Valeant Pharmaceuticals International (previously ICN Pharmaceuticals)

• Assistance with establishment of joint venture in China
• Assistance with importation, domestic manufacturing, licensing and distribution of pharmaceutical products

Top